The increasing incidence of chronic illnesses like diabetes, heart disease, and cancer, along with technological developments in the production of novel pharmaceutical drug delivery devices, are the main factors driving the global pharmaceutical drug delivery market. The International Agency for Research on Cancer estimates that 10 million cancer deaths and 19.3 million new cases of cancer will be reported worldwide in 2020. Globally, an estimated 28.4 million new cases of cancer are expected to be reported in 2040. As to the World Health Organization, cardiovascular illnesses account for around 17.9 million fatalities worldwide, or 32 percent of all deaths, and are the primary cause of mortality worldwide. The International Diabetes Federation projects that by 2045, there will be 783 million diabetics worldwide. Diabetes is a common cause of stroke, heart attacks, kidney failure, and blindness. As a result, the demand for novel medications for treatment is rising sharply due to the fast increasing prevalence of different chronic diseases worldwide, which also raises the need for pharmaceutical drug delivery systems.
Pharmaceutical drug delivery market expansion is largely being driven by the quickly expanding biopharmaceutical sector and the creation of numerous novel and cutting-edge pharmaceuticals within the sector. The need for different pharmaceutical drug delivery options is increasing globally as a result of the leading pharmaceutical companies’ increasing spending in the research and development of new treatments to cure incurable diseases. Furthermore, the pharmaceutical drug delivery market is growing due to the presence of multiple major players and their adoption of important developmental tactics like partnerships, mergers, and acquisitions, as well as the introduction of new products. Consequently, the global drug and gene delivery device industry’s increasing penetration is driving the market’s expansion.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Pharmaceutical Drug Delivery Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Pharmaceutical Drug Delivery Market Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Pharmaceutical Drug Delivery Market based on Route of Administration:
- Topical drug delivery
- Other drug delivery
- Oral drug delivery
- Nasal drug delivery
- Ocular drug delivery
Pharmaceutical Drug Delivery Market based on Application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Others
Pharmaceutical Drug Delivery Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The administration of drugs or other therapeutic substances to produce the intended therapeutic effects is referred to as pharmaceutical drug delivery. It entails creating and refining a range of techniques, frameworks, and tools to securely and efficiently administer medications to particular bodily locations. It seeks to maximize drug efficacy, reduce risk of side effects, increase bioavailability, and promote patient adherence. Oral (via tablets, capsules, or liquids), injectable, transdermal (through patches), topical (applied to the skin or mucous membranes), and other specialized techniques are common medication delivery modalities. The accurate and regulated administration of medicinal substances is made easier by these drug delivery systems, which also guarantee patient comfort and safety.
The pharmaceutical drug delivery market is divided into segments based on application, region, and mode of administration. The market is divided into many segments based on the route of administration, which include oral, nasal, ocular, topical, and other medication delivery. The market is divided into segments based on application, such as diabetes, cardiovascular, cancer, and others. The pharmaceutical drug delivery market size is broken down by region, encompassing North America (the United States, Canada, and Mexico), Europe (the United Kingdom, Germany, France, Italy, Spain, and other regions), Asia-Pacific (South Korea, China, Japan, Australia, and India), and Latin America and the Arabian Peninsula (Brazil, South Africa, Saudi Arabia, and other countries).
Oral medication delivery, nasal drug delivery, ocular drug delivery, topical drug delivery, and other drug delivery are the market segments. In 2022, the pharmaceutical medication delivery sector held the greatest market share, and it is anticipated that this segment would continue to hold this position during the projected period. This is linked to a rise in the use of injectable medication administration because of its quick start of action, precise drug delivery, and strong preference for emergency use.
The market is divided into categories such as diabetes, heart disease, cancer, and other conditions. In 2022, the pharmaceutical medication delivery market share held by the others category was the highest, and this trend is expected to persist during the forecast period. This is explained by the rise in the occurrence of respiratory conditions like asthma.
The markets in North America, Europe, Asia-Pacific, and Latin America are examined. According to industry forecasts, North America will continue to hold a significant portion of the pharmaceutical drug delivery market in 2022 and beyond. The market is growing due to the presence of numerous large players, including Novartis AG, Pfizer Inc., F. Hoffmann La-Roche Ltd., and Merck and Co., Inc., as well as the rising prevalence of diabetes in the area. For example, the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report 2020 estimates that approximately 34.2 million people (10.5%) in the United States have diabetes.
- This report illustrates the most vital attributes of the Pharmaceutical Drug Delivery Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Pharmaceutical Drug Delivery Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Pharmaceutical Drug Delivery Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Pharmaceutical Drug Delivery Market.
List of Tables
TABLE 1. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 2. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR TOPICAL DRUG DELIVERY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR OTHER DRUG DELIVERY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR ORAL DRUG DELIVERY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR NASAL DRUG DELIVERY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR OCULAR DRUG DELIVERY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 8. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. PHARMACEUTICAL DRUG DELIVERY MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 15. U.S PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 16. U.S PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. CANADA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 18. CANADA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 19. MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 20. MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 21. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 22. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 23. EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 24. GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 25. GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. U.K PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 27. U.K PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 28. FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 29. FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. ITALY PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 31. ITALY PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 32. SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 33. SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 34. ROE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 35. ROE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 37. ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 38. ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. CHINA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 40. CHINA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. INDIA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 42. INDIA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 43. JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 44. JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. REST OF APAC PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 46. REST OF APAC PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 47. LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 48. LATIN AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 50. BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 52. ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 53. MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 54. MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 56. SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 57. UAE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 58. UAE PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 59. REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD BILLION)
TABLE 60. REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. BAYER AG: FINANCIALS
TABLE 62. BAYER AG: PRODUCTS & SERVICES
TABLE 63. BAYER AG: RECENT DEVELOPMENTS
TABLE 64. BECTON, DICKINSON AND COMPANY: FINANCIALS
TABLE 65. BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES
TABLE 66. BECTON, DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 67. F. HOFFMANN-LA ROCHE AG: FINANCIALS
TABLE 68. F. HOFFMANN-LA ROCHE AG: PRODUCTS & SERVICES
TABLE 69. F. HOFFMANN-LA ROCHE AG: RECENT DEVELOPMENTS
TABLE 70. GLAXOSMITHKLINE PLC: FINANCIALS
TABLE 71. GLAXOSMITHKLINE PLC: PRODUCTS & SERVICES
TABLE 72. GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS
TABLE 73. JOHNSON & JOHNSON: FINANCIALS
TABLE 74. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 75. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 76. MERCK & CO., INC.: FINANCIALS
TABLE 77. MERCK & CO., INC.: PRODUCTS & SERVICES
TABLE 78. MERCK & CO., INC.: RECENT DEVELOPMENTS
TABLE 79. NOVARTIS AG: FINANCIALS
TABLE 80. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 81. NOVARTIS AG: DEVELOPMENTS
TABLE 82. 3M COMPANY: FINANCIALS
TABLE 83. 3M COMPANY: PRODUCTS & SERVICES
TABLE 84. 3M COMPANY: RECENT DEVELOPMENTS
TABLE 85. PFIZER INC.: FINANCIALS
TABLE 86. PFIZER INC.: PRODUCTS & SERVICES
TABLE 87. PFIZER INC.: RECENT DEVELOPMENTS
TABLE 88. SANOFI: FINANCIALS
TABLE 89. SANOFI: PRODUCTS & SERVICES
TABLE 90. SANOFI: RECENT DEVELOPMENTS
